Skip to main content
. 2020 Jan 13;98(2):skaa005. doi: 10.1093/jas/skaa005

Table 1.

Treatment protocol for first and subsequent BRD treatments

BRD treatment sequence Treatment decision cutoffs Treatment
No treatment Visual signs of BRD, rectal temperature <40°C and CALA score <2 No treatment
First treatment-less severe BRD, <60 DOF Visual signs and CALA score 2, or no visual signs and CALA score 2, or visual signs and rectal temperature ≥40°C, or no visual signs and rectal temperature ≥40°C Tilmicosin (Micotil, Elanco Animal Healthy, West Ryde, Australia)
First treatment-severe BRD, <60 DOF CALA score 3 with or without visual signs, or rectal temperature ≥ 40°C and CALA score ≥2 with or without visual signs Tulathromycin (Draxxin, Zoetis Animal Health, NJ, USA)
Second treatment Pulled for BRD a second time or received Tulathromycin for the first BRD treatment Oxytetracycline (Engemycin, MSD Animal Health, Wellington, New Zealand)
Third treatment Pulled for BRD a third time Florfenicol (Nuflor, Merck Animal Health, Madison, NJ, USA) and Meloxicam (Troy Laboratories, Glendenning, Australia)
First treatment ≥60 DOF, or fourth BRD treatment Treated regardless of rectal temperature of CALA score, or pulled for BRD a fourth time Ceftiofur (Excede, Zoetis Animal Health, Lincoln, NE, USA)